Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Retinoblastoma 26Advanced Solid Tumors 18Mesothelioma 16Mesothelioma, Malignant 15Unspecified Adult Solid Tumor, Protocol Specific 13Solid Tumors 9Advanced Solid Tumor 6Solid Tumor 4Neuroblastoma 4Unspecified Childhood Solid Tumor, Protocol Specific 3Sarcoma 3Retinal Neoplasms 3Ovarian Neoplasms 3Neoplasms 3Medulloblastoma 3Central Nervous System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Wilms Tumor 2Testicular Neoplasms 2Solid Tumor, Adult 2Rhabdoid Tumor 2Relapsed Pediatric Solid Tumor 2Osteosarcoma 2Optic Nerve Glioma 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma 2Choroid Plexus Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Astrocytoma 2

Interventions

adavosertib 5durvalumab 3Paclitaxel 3olaparib 2ceralasertib 2Fluorouracil 2Carboplatin 2toripalimab 1sintilimab 1pembrolizumab 1factor IX, factor VII, factor X, prothrombin drug combination 1drug XX Z 1danvatirsen 1capivasertib 1Rifampin 1Pantoprazole 1Omeprazole 1Leucovorin 1Itraconazole 1Irinotecan 1Injections 1Gemcitabine 1Doxorubicin 1Cisplatin 1AZD0156 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Solid Tumours × Carboplatin × Other solid neoplasm × Clear all
NCT03421353 2024-08-21

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

AstraZeneca

Phase 1 Completed
76 enrolled
Other solid neoplasm

Advanced Solid Tumours

NCT02341456 2019-03-25

Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours

AstraZeneca

Phase 1 Completed
19 enrolled 53 charts
Other solid neoplasm

Advanced Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡